The stock of Aurora Cannabis Inc (NASDAQ: ACB) has increased by 3.24 when compared to last closing price of 3.70.Despite this, the company has seen a loss of -1.29% in its stock price over the last five trading days. prnewswire.com reported 2025-01-23 that NASDAQ | TSX: ACB Investment in the region continues with the launch of IndiMed, the company’s first locally grown brand in Germany EDMONTON, AB, Jan. 23, 2025 /PRNewswire/ – Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company’s first German-cultivated medical cannabis product, under the brand IndiMed. Manufactured at Aurora’s leading EU-GMP facility in Leuna, Germany, the new brand offers a supply of high-quality, locally grown and sold, medical cannabis for the country’s expanding patient base.
Is It Worth Investing in Aurora Cannabis Inc (NASDAQ: ACB) Right Now?
Additionally, the 36-month beta value for ACB is 1.85. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 4 rating it as “hold,” and 0 rating it as “sell.”
The public float for ACB is 54.65M and currently, short sellers hold a 7.82% ratio of that float. The average trading volume of ACB on January 31, 2025 was 877.11K shares.
ACB’s Market Performance
ACB’s stock has seen a -1.29% decrease for the week, with a -11.16% drop in the past month and a -35.80% fall in the past quarter. The volatility ratio for the week is 4.21%, and the volatility levels for the past 30 days are at 4.70% for Aurora Cannabis Inc The simple moving average for the last 20 days is -6.35% for ACB’s stock, with a simple moving average of -30.90% for the last 200 days.
ACB Trading at -9.88% from the 50-Day Moving Average
After a stumble in the market that brought ACB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -59.14% of loss for the given period.
Volatility was left at 4.70%, however, over the last 30 days, the volatility rate increased by 4.21%, as shares sank -9.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.98% lower at present.
During the last 5 trading sessions, ACB fell by -1.29%, which changed the moving average for the period of 200-days by -42.12% in comparison to the 20-day moving average, which settled at $4.08. In addition, Aurora Cannabis Inc saw -10.12% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ACB
Current profitability levels for the company are sitting at:
- -0.16 for the present operating margin
- 0.54 for the gross margin
The net margin for Aurora Cannabis Inc stands at -0.23. The total capital return value is set at -0.04. Equity return is now at value -5.53, with -3.56 for asset returns.
Based on Aurora Cannabis Inc (ACB), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at -0.55. The debt to equity ratio resting at 0.19. The interest coverage ratio of the stock is -3.59.
Currently, EBITDA for the company is 20.47 million with net debt to EBITDA at -0.41. When we switch over and look at the enterprise to sales, we see a ratio of 1.51. The receivables turnover for the company is 4.3for trailing twelve months and the total asset turnover is 0.23. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.83.
Conclusion
In conclusion, Aurora Cannabis Inc (ACB) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
